James Kuiken
Fortuna: 573 461 $ al 30/09/2026
Fortuna: 573 461 $ al 30/09/2026
James M.
Kuiken is currently Operations Director at Roche Molecular Systems, Inc. since 2014 and Independent Director at Columbia Financial, Inc. (Maryland).
Formerly, Mr. Kuiken was Independent Non-Executive Director at Columbia Financial, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,02 % | 20/07/2026 | 51.850 ( 0,02 % ) | 573 461 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Director de Operaciones | 01/04/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
Columbia Financial, Inc.
Columbia Financial, Inc. Savings BanksFinance Operates as a bank holding company whose subsidiaries engages in federally chartered savings banking activities | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Columbia Financial, Inc.
Columbia Financial, Inc. Savings BanksFinance Operates as a bank holding company whose subsidiaries engages in federally chartered savings banking activities | Finance |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.